Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Mallinckrodt
Boehringer Ingelheim
Express Scripts
Harvard Business School

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017824

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 017824 describes HALOG, which is a drug marketed by Sun Pharm Inds Inc, Westwood Squibb, and Bristol Myers Squibb, and is included in six NDAs. It is available from two suppliers. Additional details are available on the HALOG profile page.

The generic ingredient in HALOG is halcinonide. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the halcinonide profile page.
Summary for 017824
Tradename:HALOG
Applicant:Sun Pharm Inds Inc
Ingredient:halcinonide
Patents:0
Pharmacology for NDA: 017824
Medical Subject Heading (MeSH) Categories for 017824
Suppliers and Packaging for NDA: 017824
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HALOG halcinonide OINTMENT;TOPICAL 017824 NDA Sun Pharmaceutical Industries, Inc. 10631-096 10631-096-30 60 g in 1 TUBE (10631-096-30)
HALOG halcinonide OINTMENT;TOPICAL 017824 NDA Sun Pharmaceutical Industries, Inc. 10631-096 10631-096-71 4 TUBE in 1 CARTON (10631-096-71) > 60 g in 1 TUBE (10631-096-30)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength0.1%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Harvard Business School
McKinsey
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.